APP and Alzheimer disease: In addition, in an in vitro model of human full-length β-amyloid precursor protein (APP) expression, the overexpression of ERRα was shown to reduce the molecular hallmarks of AD, i.e., processing APP into its amyloidogenic fragments and Tau phosphorylation [92].